Categories: Healthcare

Darbepoetin Alfa (Aranesp) Market Growth Outlook Through 2024-2033

Overview and Scope

Darbepoetin alfa (Aranesp) is a medication used to treat anemia brought on by chemotherapy and chronic kidney disease. It helps the bone marrow make more red blood cells.

Sizing and Forecast

The darbepoetin alfa (aranesp) market size has grown strongly in recent years. It will grow from $5.56 billion in 2023 to $5.88 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to anemia treatment advancements, erythropoiesis-stimulating agents (esa) demand, biopharmaceutical innovation, clinical acceptance, improved patient outcomes.

The darbepoetin alfa (aranesp) market size is expected to see steady growth in the next few years. It will grow to $7.11 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to healthcare reimbursement policies, increased awareness and education, healthcare infrastructure development, renal care demands, aging population. Major trends in the forecast period include global market penetration, digital health integration, personalized treatment approaches, adoption of biosimilars, long-acting formulations.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/darbepoetin-alfa-aranesp-global-market-report

Segmentation & Regional Insights

The darbepoetin alfa (aranesp) market covered in this report is segmented –

1) By Type: Epogen, Procrit, Aranesp, Other Types
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Patients with Chronic Kidney Disease, Patients with Cancer, Other Applications

North America was the largest region in the darbepoetin alfa market in 2023. The regions covered in the darbepoetin alfa (aranesp) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12171&type=smp

Major Driver Impacting Market Growth

The increase in the prevalence of chronic diseases is expected to propel the growth of the darbepoetin alfa market going forward. A chronic disease is a form of illness that lasts three months or more and can deteriorate with time. Darbepoetin alfa is used to treat various chronic diseases, to reverse chemotherapy-induced anemia in cancer. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least one chronic condition would increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Therefore, an increase in the prevalence of chronic diseases is driving the growth of the darbepoetin alfa market.

Key Industry Players

Major companies operating in the darbepoetin alfa (aranesp) market report are Johnson & Johnson, Amgen Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Serum Institute of India Pvt. Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Biocon Ltd., Reliance Life Sciences, Torrent Pharmaceuticals Ltd., 3SBio Inc., Cadila Healthcare Ltd., Dong-A ST Co. Ltd., Chong Kun Dang Holdings, Hetero Drugs Ltd., Intas Pharmaceuticals Ltd., Avesthagen Pharma, Stada Arzneimittel AG, Ranbaxy Laboratories Ltd., Sandoz International GmbH, Shandong Kexing Bioproducts Co. Ltd., Iko Pharmaceutical Co. Ltd., Menagen Pharmaceutical Industries, Kyowa Kirin Co. Ltd., Polifarma S.p.A.

The darbepoetin alfa (aranesp) market report table of contents includes:

1. Executive Summary

2. Darbepoetin Alfa (Aranesp) Market Characteristics

3. Darbepoetin Alfa (Aranesp) Market Trends And Strategies

4. Darbepoetin Alfa (Aranesp) Market – Macro Economic Scenario

5. Global Darbepoetin Alfa (Aranesp) Market Size and Growth

32. Global Darbepoetin Alfa (Aranesp) Market Competitive Benchmarking

33. Global Darbepoetin Alfa (Aranesp) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Darbepoetin Alfa (Aranesp) Market

35. Darbepoetin Alfa (Aranesp) Market Future Outlook and Potential Analysis

36. Appendix

Email: info@tbrc.info